Financials
- Market Capitalization 2.41 B
- Employee 63
- Founded 1990
- CEO N/A
- Website www.nektar.com
- Headquarter Delaware, United States
- FIGI BBG000BHCYJ1
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-9.07
ratio cours/chiffre d'affaires
22.86
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1846 | RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 24.78 USD | -4.84% | -7.74% | -25.20% | -8.70% | 2.44 B USD | ||
| 1854 | NRIX Nurix Therapeutics, Inc. - Common stock | 23.27 USD | -1.31% | -1.48% | -5.44% | +107.58% | 2.41 B USD | ||
| 1875 | VCEL Vericel Corporation - Common Stock | 45.78 USD | -3.84% | +2.19% | +2.53% | +25.94% | 2.34 B USD | ||
| 1887 | VERA Vera Therapeutics, Inc. - Class A Common Stock | 32.20 USD | -2.57% | -11.17% | -24.73% | +8.27% | 2.31 B USD |